We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR Reveals New Targets for Promising Cancer Drugs

News   Jul 20, 2017 | Original story from Harvard University

 
CRISPR Reveals New Targets for Promising  Cancer Drugs

redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had essential immune evasion genes knocked out.

 
 
 

RELATED ARTICLES

A Third "Short Sleep" Gene Has Been Discovered – And It Prevents Memory Deficits

News

In a new study, scientists have discovered a third "short sleep" gene. It is the first gene to be identified that prevents the memory deficits typically associated with sleep deprivation.

READ MORE

The Next Generation of Hearing Implants Could Be Soft

News

Close to half a million people around the world suffer from a serious hearing impairment. Cochlear implants, whilst useful for some patients, do not help people whose inner ear is damaged or whose auditory nerve does not function properly. Now, researchers have developed a soft variant of an implant that communicates directly with the brainstem.

READ MORE

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE